IJ Psychiatry and Behavioral Sciences
IJPBS is the Official Journal of Mazandaran University of Medical Sciences
Crossref
1. Lessons From Clinical Trials of Immunomodulatory Drugs in Psychiatric Disorders
- Thomas Pak
- Nabila Haque
- Manish K. Jha
2. Antipsychotic Effects of Celecoxib Add-On Haloperidol in Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial
- Mehran Zarghami
- Nasrin Dodangi
- Paria Azari
- Alireza Khalilian
3. COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
- Norbert Müller
4. Linking Metabolic Disorders and Immune System Phenomena in Schizophrenia: The Role of Adipose Tissue and Inflammation
- Aleksandra Julia Oracz
- Mateusz Zwierz
- Maciej Naumowicz
- Stefan Modzelewski
- Maria Suprunowicz
- Napoleon Waszkiewicz
5. Antithrombotic agents in the treatment of severe mental illness: A systematic review and meta-analysis of randomized controlled trials
- Caroline Fussing Bruun
- Mette Ungermann Fredskild
- Maria Faurholt-Jepsen
- Maj Vinberg
- Lars Vedel Kessing
- Klaus Munkholm
6. Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing
- Jonghee Hong
- Minji Bang
7. The Role of Inflammation in the Treatment of Schizophrenia
- Guillaume Fond
- Christophe Lançon
- Theo Korchia
- Pascal Auquier
- Laurent Boyer
8. Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment Targets
- Abbas F. Almulla
- Michael Maes
9. Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms in patients with schizophrenia: a meta-analysis
- Honglian Li
- Hong Shen
- Xueyu Duan
- Meixian Guo
- Xiaobo Liu
10. Microglia and microbiome in schizophrenia: can immunomodulation improve symptoms?
- Georg Juckel
- Nadja Freund